Insights Into Curis Inc. (CRIS) Exposure By Institutions

After Hours

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. After-hours trades for Curis Inc. (CRIS) shows that investor sentiment remained broken, with the stock’s consolidated last price falling by -$0.0211, or -2.70%, to $0.76. Volume reached 18,792 shares, with price reaching a high of $0.7979 and a low of $0.764. Most recently, Yahoo Finance reported about the stock as it publicized that Curis Announces Date for the 2nd Annual VISTA Symposium.


Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now.

Sponsored

Stocks Info

Curis Inc. is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. At the end of the last regular session, the stock closed at $0.78 and fluctuated between $0.7998 as its day high and $0.7600 as its day low. The current market capitalization of Curis Inc. is $74.07M. A total of 1.3 million shares were traded on the day, compared to an average of 3.08M shares.

Insider trades are also considered as indicators of how a stock will perform in the future, in addition to stock predictions. During the recent three months, CRIS has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 0 BUYs and 2 SELLs from insiders. Insiders purchased 0 shares during that period but sold 5,500.

In the most recent transaction, Dentzer James E sold 3,094 shares of CRIS for 3.07 per share on Jan 31. After the transaction, the President & CEO now owns 64,877 company shares. In a previous transaction on Jan 27, Dentzer James E sold 2,406 shares at 3.18 per share. CRIS shares that President & CEO owns now total 67,971.

Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. According to analysts who have offered 12-month price targets for CRIS in the last 3 months, the mean price target is $12.00 with high estimates of $22.00 and low estimates of $3.00. In terms of 52-week highs and lows, CRIS has a high of $8.50 and a low of $0.70.

As of this writing, CRIS has an earnings estimate of $-0.17 per share for the current quarter. EPS was calculated based on a consensus of 2 estimates, with a high estimate of $-0.17 per share and a lower estimate of $-0.17.

Balance Sheet Annually/Quarterly

As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information.

Analysts Opinion

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 5 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CRIS is Overweight with a score of 4.00. A total of 4 analysts rated the stock as Buy while 0 rated it as Overweight while 1 rated it as Hold. Among the other participants, 0 thought the stock was Underweight and 0 thought it should be Sold.

Related Articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest Articles

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

The 5 Best Inflation Stocks for 2022

292
294

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

The 5 Best Inflation Stocks for 2022

100% free. stop anytime no spam

Get our free report on the stocks that we recommend for investors who want to protect their portfolios from inflation.